Genetic markers for inherited thrombophilia are associated with fetal growth retardation in the population of Central Russia

J Obstet Gynaecol Res. 2017 Jul;43(7):1139-1144. doi: 10.1111/jog.13329. Epub 2017 May 19.

Abstract

Aim: The aim of this study was to examine the role of hereditary thrombophilia in the development of fetal growth retardation (FGR) in the population of Central Russia.

Methods: The case-control study sample included 497 women in the third trimester of pregnancy recruited during 2009-2013. The participants were enrolled into two groups: patients with FGR (n = 250) and controls without FGR (n = 247). The participants were genotyped for four genetic markers of hereditary thrombophilia: factor V Leiden (G > A FV, rs6025), prothrombin (G > A FII, rs1799963), factor VII (G > A FVII, rs6046), and fibrinogen (G > A FI, rs1800790).

Results: The genetic factors for an increased risk of FGR were allele G of rs6046 (odds ratio [OR] = 2.34) and genotype GG of rs6046 (OR = 2.64), whereas genotype GA of rs6046 had the protective value (OR = 0.42). A combination of alleles G of rs1799963, A of rs6046, and G of rs1800790 (OR = 0.31) reduces the risk of FGR.

Conclusion: Polymorphism rs6046 of the FVII gene is associated with the development of FGR.

Keywords: factor VII coagulant; fetal growth retardation; pregnancy; single nucleotide polymorphism.

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Factor V / genetics
  • Factor VII / genetics*
  • Female
  • Fetal Growth Retardation / epidemiology
  • Fetal Growth Retardation / genetics*
  • Fibrinogen / genetics
  • Genetic Markers
  • Humans
  • Middle Aged
  • Pregnancy / blood*
  • Prothrombin / genetics
  • Russia / epidemiology
  • Thrombophilia / genetics*
  • Young Adult

Substances

  • Genetic Markers
  • factor V Leiden
  • Factor V
  • Factor VII
  • Prothrombin
  • Fibrinogen

Supplementary concepts

  • Thrombophilia, hereditary